Clinical Trial Update: OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma [Phase 3]

View source ↗

Summary

Clinical trial update for the Phase 3 OptiMATe study evaluating de-escalated induction treatment in primary central nervous system lymphoma; the trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: Klinikum Stuttgart | Conditions: Primary Central Nervous System Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING